Skip to main content
Clinical Trials/JPRN-UMIN000015101
JPRN-UMIN000015101
Completed
Phase 1

A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinoma - A phase 1 trial of HAIC with high dose CDDP + 5-FU for advanced HCC

Keio University, School of medicine, Department of Surgery0 sites18 target enrollmentSeptember 10, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Keio University, School of medicine, Department of Surgery
Enrollment
18
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 10, 2014
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Keio University, School of medicine, Department of Surgery

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Active second primary malignancies. (2\) Within 3 years after radical treatment of another cancer (3\) With extrahepatic metastasis. (4\) Patients with ascites possessed clinical meaning. (5\) Hepatic Encephalopathy (6\) Critical renal failure or hemodialysis (7\) Contraindication of CDDP and 5\-FU (8\) Any patients are pregnant/ nursing (9\) After administration of TS\-1 (10\) Auditory disorder (11\) Patients with serious infection (12\) Gastrointestinal ulcer or bleeding (13\) Uncontrolled DM (14\) Those judged to be not suitable by the attending physician

Outcomes

Primary Outcomes

Not specified

Similar Trials